Identification of e19a2 BCR-ABL fusions (μ-BCR breakpoints) at the DNA level by ligation-mediated PCR [13]

Leukemia

Volumn 19, Issue 7, 2005, Pages 1292-1295

  Boeckx, N ^a   Jansen, M W J C ^b   Haskovec, C ^c   Vandenberghe, P ^d   van der Velden, V H J ^b   van Dongen, J J M ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; HYDROXYUREA; IMATINIB; DNA;

AGED; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; DNA STRAND BREAKAGE; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; INTRON; LETTER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; CHROMOSOME BREAKAGE; FATALITY; GENETICS; METHODOLOGY; MYELOID LEUKEMIA; POLYMERASE CHAIN REACTION;

AGED; CHROMOSOME BREAKAGE; DNA; FATAL OUTCOME; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; POLYMERASE CHAIN REACTION;

EID: 21744458761     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403761     Document Type: Letter

References (10)

1. van Dongen JJM, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Sagli G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901-1928.
2. Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996; 88: 2410-2414.
3. Haskovec C, Ponzetto C, Polak J, Maritano D, Zemanova Z, Serra A et al. P230 BCR/ABL protein may be associated with an acute leukaemia phenotype. Br J Haematol 1998; 103: 1104-1108.
4. Wada H, Mizutani S, Nishimura J, Usuki Y, Kohsaki M, Komai M et al. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein. Cancer Res 1995; 55: 3192-3195.
5. Przybylski GK, Dik WA, Wanzeck J, Grabarczyk P, Majunke S, Martin-Subero I et al. Disruption of the BCL11B gene through inv14(q11.2;q32.31) results in expression of BCL11B-TCRD fusion transcripts and is associated with absence of wild-type BCL11B transcripts in T-ALL. Leukemia 2005; 19: 201-208.
6. Jeffs AR, Benjes SM, Smith TL, Sowerby SJ, Morris CM. The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia. Hum Mol Genet 1998; 7: 767-776.
7. Zhang JG, Goldman JM, Cross N. Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR. Br J Haematol 1995; 90: 138-146.
8. Jiang XY, Trujillo JM, Liang JC. Chromosomal breakpoints within the first intron of the ABL gene are nonrandom in patients with chronic myelogenous leukemia. Blood 1990; 76: 597-601.
9. Waller CF, Dennebaum G, Feldmann C, Lange W. Long-template DNA polymerase chain reaction for the detection of the bcr/abl translocation in patients with chronic myelogenous leukaemia. Clin Cancer Res 1999; 5: 4146-4151.
10. Verstovsek S, Lin H, Kantarjian H, Saglio G, De Micheli D, Pane F et al. Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR-ABL mRNA and undetectable p230 BCR-ABL protein may predict indolent course. Cancer 2002; 94: 2416-2425.